However, none of the vaccine trials have passed large-scale, late-stage phase 3 clinical trials, a necessary step before getting regulatory approval for sale.
IMBCAMS began on Saturday a phase 2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing in humans, following an on-going phase-1 study that has recruited about 200 participants since May, the institute said on Sunday in its social media channel.
The phase-2 trial will determine the shot's dose and continue to evaluate whether the potential vaccine can safely trigger immune responses in healthy people.
IMBCAMS said it expects to use a plant dedicated to producing a coronavirus vaccine this year to prepare for China's future vaccine supplies.
As early as by the end of 2020, certain groups of people with special needs can use experimental vaccines under urgent circumstances, Gao Fu, director at the Chinese Center for Disease Control and Prevention, said last month.
The coronavirus, which was first detected in China late in 2019, has infected 8.81 million people globally and killed more than 460,000 people.
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Beijing officials declare outbreak ‘under control’
China launches final satellite to complete rival to GPS
Chinese firm sued by US over 'fake' masks not certified
China suspends imports of poultry from US plant over Covid-19
Beijing tests food and parcel couriers as coronavirus checks widen
Beijing tests food, parcel couriers for coronavirus as city checks widen
China inspects foodstuff imports over virus fears
Beijing’s virus outbreak is under control: expert
Beijing cancels flights, shuts schools over new virus cases